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More than two decades have passed since Sydney Coleman revolutionized autolo-gous fat grafting by his defined protocol.1 
Ever since, an exponentially rising number of 
publications have resulted in uncountable modi-
fications of fat graft harvest, processing, and injec-
tion techniques, with the ultimate goal to increase 
retention and the regenerative potential of the 
grafted adipose tissue. Coleman’s technique 
includes the harvest of adipose tissue by a blunt 
cannula followed by centrifugation of the lipoaspi-
rate, which leads to three distinct layers: an upper 
oily layer, a middle purified fat layer, and a lower 
watery layer. After removal of the oily and watery 
layer, only the purified fat is routinely reinjected.
Earlier, we provided evidence that lipoaspi-
rates contained significant amounts of basic fibro-
blast growth factor (bFGF), insulin-like growth 
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Background: Adipose-derived stem cells, endothelial progenitor cells, and 
soluble factors jointly contribute to the regenerative effect of fat grafts. Nano-
fat grafting emulsifies the lipoaspirate and increases the progenitor cell yield. 
In the present study, the authors evaluated their extended nanofat grafting 
method that includes two additional centrifugation steps and results in a li-
poaspirate of low volume that they termed “lipoconcentrate.” Furthermore, 
the authors investigated the oily fractions after centrifugation for their regen-
erative potential.
Methods: Lipoaspirates of 20 healthy patients were processed by emulsifi-
cation and/or centrifugation. Six groups were created: native (not emul-
sified) fat, 1× centrifuged native fat, 2× centrifuged native fat, nanofat 
(emulsified), 1× centrifuged nanofat, and lipoconcentrate (i.e., 2× centri-
fuged nanofat). The oily phases after the centrifugation steps were collect-
ed. Progenitor cells and basic fibroblast growth factor, insulin-like growth 
factor 1, matrix metalloproteinase-9, platelet-derived growth factor-BB, and 
vascular endothelial growth factor-A levels were measured by flow cytometry 
and immunoassays.
Results: Lipoconcentrate contained significantly higher numbers of adipose-
derived stem cells and endothelial progenitor cells per gram compared with 
all other fractions. No difference of all five soluble factors between groups was 
found. The oily phases after centrifugation showed no or very few adipose-
derived stem cells and endothelial progenitor cells, and no or very low levels 
of soluble factors.
Conclusions: Centrifugation of emulsified lipoaspirates increases the pro-
genitor cell count in the lipoaspirate. The oily phase after centrifugation of 
 lipoaspirates may be disposable because of the minuscule content of progeni-
tor cells and soluble factors. (Plast. Reconstr. Surg. 142: 99, 2018.)
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factor 1 (IGF-1), platelet-derived growth factor 
(PDGF), and vascular endothelial growth factor 
(VEGF).2 The concentration of growth factors 
and other soluble factors in the transferred fat 
graft is of key importance, as they promote cen-
tral angiogenic effects and increase the take rate 
of the fat graft.
Aside from soluble factors, progenitor cells 
such as adipose-derived stem cells and endothelial 
progenitor cells represent the second regenerative 
pillar of fat grafts. Adipose-derived stem cells are 
multipotent mesenchymal stem cells with a mul-
tilineage differentiation capacity, and endothelial 
progenitor cells are important progenitor cells 
that contribute to volume retention and neovas-
cularization of fat grafts.3,4 Numerous techniques 
have been proposed to enhance, in particular, the 
number of adipose-derived stem cells in the fat 
graft.5 One simple maneuver to increase the pro-
genitor cell content in fat grafts is the mechanical 
emulsification of adipose tissue, a technique called 
“nanofat grafting” suggested by Tonnard et al.6 
According to the authors, noncentrifuged lipoaspi-
rates are shifted between two syringes through a 
Luer-Lok (Becton, Dickinson and Co., Franklin 
Lakes, N.J.) connector, leading to a disruption of 
adipocytes and concentration of progenitor cells.
In recent years, we have used a modification 
of Tonnard et al.’s original protocol by adding 
two centrifugation steps, ultimately resulting in a 
lipoaspirate with very little volume that we termed 
“lipoconcentrate.” In the present study, we evalu-
ated lipoconcentrate for its content of progenitor 
cells and important regenerative soluble factors. 
We compared lipoconcentrate with multiple con-
trol groups processed by various steps of emul-
sification and/or centrifugation to validate the 
necessity of each step of the lipoconcentrate prep-
aration protocol.
Although we and other authors showed earlier 
that the watery fraction may have untoward effects 
and contains few growth factors, we also aimed 
to deliver scientific evidence for the removal of 
the oily fractions after centrifugation of lipoaspi-
rates.2,7 Thus, we further investigated the progeni-
tor cell concentration and soluble factor levels in 
oily fractions after centrifugation.
PATIENTS AND METHODS
Patients and Adipose Tissue Harvest
Adipose tissue was harvested from the abdom-
inal area of 20 healthy patients (six men and 14 
women), with a mean age of 44.65 ± 3.73 years 
and a mean body mass index of 27.99 ± 1.23 kg/
m2, undergoing surgery at the Department of 
Plastic and Reconstructive Surgery, Hand Sur-
gery–Burn Center at the University Hospital in 
Aachen. (See Table, Supplemental Digital Con-
tent 1, which shows the list of patients, http://
links.lww.com/PRS/C804.) After injection of a 
tumescent solution (sodium chloride 0.9% with 
epinephrine 1:800,000), lipoaspirates were har-
vested by means of a microfat grafting st’RIM can-
nula (Thiebaud Biomedical Devices, Margencel, 
France) connected to a 10-cc hand-held syringe as 
reported earlier.8,9 Patients younger than 18 years 
or with a history of malignancies; autoimmune 
and cardiovascular diseases; or morbidities on the 
donor site such as scars, wound healing disorder, 
and dermatologic issues were excluded from the 
study. All operations were performed by a single 
plastic surgeon (N.P.). The use of human samples 
was approved by the regional ethics committee 
(EK163/07), and all experiments were conducted 
in compliance with the principles outlined in the 
Declaration of Helsinki.
Sample Preparation
Each of the 20 samples was divided into eight 
different fractions and further investigated as illus-
trated in Figure 1. All centrifugation steps were per-
formed according to the Coleman protocol at 1200 
g for 3 minutes.10 Nanofat preparation (i.e., emul-
sification) included shifting of the lipoaspirate 30 
times between two 10-ml syringes connected by a 
Luer-Lok female-to-female connector as described 
by Tonnard et al.6 Samples were harvested, imme-
diately processed, and transferred to the labora-
tory. The eight fractions included were as follows:
1. Native fat: Lipoaspirate after harvest with-
out further manipulation.
2. 1× centrifuged native fat: The native fat 
was centrifuged. The resulting upper oily 
fraction and lower watery fraction were dis-
carded, and the middle purified layer was 
collected.
3. Oily fraction: Upper oily layer after centrifu-
gation of the native fat.
4. 2× centrifuged native fat: The 1× centri-
fuged native fat was centrifuged again. The 
resulting upper oily fraction and lower 
watery fraction were discarded, and the 
middle purified layer was collected.
5. Nanofat: Native fat underwent emulsifica-
tion by the nanofat grafting protocol with-
out centrifugation.
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Fig. 1. Scheme for preparation of different fractions. For each patient, different fractions 
were collected as depicted. All centrifugation steps were performed according to the Cole-
man protocol at 1200 g for 3 minutes (Coleman SR. Facial recontouring with lipostructure. 
Clin Plast Surg. 1997;24:347–367). Emulsification included shifting of the lipoaspirate for 
30 times between two 10-ml syringes connected by a Luer-Lok female-to-female connec-
tor (Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat graft-
ing: Basic research and clinical applications. Plast Reconstr Surg. 2013;132:1017–1026). All 
fat grafts were harvested with a microfat grafting cannula, resulting in native fat. Native 
fat is lipoaspirate after harvest without further manipulation. The native fat was either 
emulsified (i.e., nanofat) or centrifuged, which resulted in an upper oily (i.e., oily fraction), 
middle purified fat (i.e., 1× centrifuged native fat), and lower watery layer. The 1× centri-
fuged native fat was either centrifuged again or emulsified (i.e., 1× centrifuged nanofat). 
The middle fat layer after the second centrifugation of the 1× centrifuged native fat was 
called 2× centrifuged native fat. The middle layer after the second centrifugation of the 1× 
centrifuged nanofat was called lipoconcentrate. The upper oily layer was termed oily frac-
tion of lipoconcentrate.
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Fig. 2. Content of bFGF, IGF-1, MMP-9, PDGF-BB, and VEGF-A. The protein content of (above, left) bFGF, 
(above, right) IGF-1, (center, left) MMP-9, (center, right) PDGF-BB, and (below) VEGF-A was measured
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6. 1× centrifuged nanofat: Native fat was first 
centrifuged. After discarding the upper oily 
fraction and lower watery fraction, the 1× 
centrifuged native fat underwent emulsifi-
cation by the nanofat grafting protocol.
7. Lipoconcentrate: Native fat was first cen-
trifuged. After discarding the upper oily 
fraction and lower watery fraction, the 1× 
centrifuged native fat underwent emulsifi-
cation by the nanofat grafting protocol. The 
resulting 1× centrifuged nanofat was centri-
fuged again. The oily fraction of lipocon-
centrate and watery fraction were removed, 
resulting in the purified liquefied fat layer 
that was termed lipoconcentrate.
8. Oily fraction of lipoconcentrate: Native fat 
was first centrifuged. After discarding the 
upper oily fraction and lower watery frac-
tion, the 1× centrifuged native fat under-
went emulsification by the nanofat grafting 
protocol. The resulting 1× centrifuged 
nanofat was centrifuged again. The result-
ing oily fraction was collected.
Measurement of bFGF, VEGF-A, PDGF-BB,  
IGF-1, and Matrix Metalloproteinase-9
Evaluation of soluble factors was performed as 
reported earlier.11 Basic FGF, VEGF-A, PDGF-BB, 
and matrix metalloproteinase (MMP)-9 contents 
of the samples were analyzed by Multiplex mag-
netic bead Immunoassay (MilliporeSigma, Bur-
lingon, Mass.). ProcartaPlex sets (eBioscience, 
Inc., San Diego, Calif.) were used according to 
the manufacturer’s guidelines and measured on 
a Luminex 200 (Luminex Corp., Austin, Texas). 
The IGF-1 content was measured by an enzyme-
linked immunosorbent assay Duo-Set (R&D 
Systems, Minneapolis, Minn.) on a FLUOstar 
OPTIMA microplate reader (BMG LABTECH, 
Aylesbury, United Kingdom) according to the 
manufacturer’s guidelines.11 The acquired con-
tent of the soluble factors were normalized to the 
protein level detected by the DC Protein Assay 
(Bio-Rad Laboratories, Inc., Hercules, Calif.).
Stromal Vascular Fraction Cell Counting and 
Surface Marker Characterization by Flow Cytometry
Stromal vascular fraction cell counting was 
performed in a standard hemocytometer after 
lysis of erythrocytes with a red blood cell lysis 
buffer (eBioscience). Trypan blue viability stain 
(Thermo Fisher Scientific, Frankfurt am Main, 
Germany) was used to exclude dead cells. For 
fractions including adipose tissue (native fat, 
1× centrifuged native fat, 2× centrifuged native fat, 
nanofat, 1× centrifuged nanofat, and lipoconcen-
trate), the stromal vascular fraction cell, adipose-
derived stem cell, and endothelial progenitor cell 
counts were calculated as cells per gram starting 
tissue before collagenase digestion. For oily frac-
tions, the stromal vascular fraction cell, adipose-
derived stem cell, and endothelial progenitor cell 
counts were calculated as cells per gram solution.
Surface markers CD31, CD34, CD45, CD73, 
CD90, and CD105 were measured by flow cytome-
try as described earlier.11 Samples including adipose 
tissue were digested with collagenase (collagenase 
type I; Worthington Biochemical Corp., Lakewood, 
N.J.), filtered, and centrifuged. The oily fraction 
and oily fraction of lipoconcentrate only were fil-
tered without further collagenase digestion.
All antibodies were purchased from eBio-
science and used for staining according to the 
manufacturer’s instructions. Details of each anti-
body are found in Supplemental Digital Content 
2. (See Table, Supplemental Digital Content 2, 
which shows the flow cytometry antibodies used, 
http://links.lww.com/PRS/C805.) Stained cells were 
evaluated by flow cytometry on an LSR II cytom-
eter (BD Bioscience, San Jose, Calif.).
Statistical Analysis
GraphPad Prism Version 5.03 (GraphPad Soft-
ware, Inc., La Jolla, Calif.) was used for data analysis. 
One-way analysis of variance with repeated measures 
and with a post hoc multiple comparison test (Bon-
ferroni) was used. All values are shown as means ± 
SEM. A value of p < 0.05 was considered significant.
RESULTS
Content of bFGF, IGF-1, PDGF-BB, VEGF-A, and 
MMP-9
There were no significant differences 
observed for bFGF, IGF-1, PDGF-BB, and VEGF-
A between native fat and nanofat (Fig. 2). 
Fig. 2. (Continued). in the eight fractions by Multiplex magnetic 
bead Immunoassay (bFGF, MMP-9, PDGF-BB, and VEGF-A) and 
enzyme-linked immunosorbent assay (IGF-1). The values were 
normalized to the total protein content. All data are presented 
as means ± SEM. Significant differences in soluble factor levels 
between the adipose tissue–containing fractions (native fat, 1× 
centrifuged native fat, 2× centrifuged native fat, nanofat, 1× 
centrifuged nanofat and lipoconcentrate) are indicated. Signifi-
cant differences of adipose tissue–containing fractions when 
compared to both oily fractions (oily fraction, oily fraction of 
lipoconcentrate) are indicated as follows: *p < 0.05; **p < 0.01; 
***p < 0.001.
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Centrifugation also did not have significant 
effects on the levels of bFGF, IGF-1, PDGF-
BB, and VEGF-A. MMP-9 levels were signifi-
cantly higher in nanofat (648.0 ± 105.0 pg/mg; 
p < 0.05) compared with native fat (374.8 ± 76.49 
pg/mg; p < 0.05). The levels of all five soluble 
factors were significantly lower in both oily frac-
tions than in the other fractions (p < 0.01 or 
p < 0.001). In most oily samples, the protein lev-
els were even below the detection limit.
Fig. 3. Cell count and content of adipose-derived stem cells and endothelial progenitor cells. For each of the 
eight fractions, the cell count and the content of adipose-derived stem cells and endothelial progenitor cells 
were measured. (Above, left) Cell counting was performed in a standard hemocytometer after lysis of erythro-
cytes with red blood cell lysis buffer. A trypan blue viability stain was used to exclude dead cells. The cell count 
was calculated as cells per gram of tissue before collagenase digestion or per gram of solution. Significant 
differences are indicated as *p < 0.05 and **p < 0.01. (Above, right) Adipose-derived stem cells were phenotypi-
cally characterized as CD31−, CD34+, CD45− cells by flow cytometry and are presented as adipose-derived stem 
cell count per gram of tissue before collagenase digestion. Significant differences are illustrated in Table 1. 
(Below) Endothelial progenitor cells were phenotypically characterized as CD31+, CD34+, CD45− cells by flow 
cytometry and are presented as endothelial progenitor cell count per gram of tissue before collagenase diges-
tion. Significant differences are illustrated in Table 2. All data are presented as means ± SEM. SVF, stromal vas-
cular fraction; ASC, adipose-derived stem cells; EPC, endothelial progenitor cells.
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Stromal Vascular Fraction Cell Count
Among samples including adipose tissue, lipo-
concentrate showed the highest concentration of 
cells after collagenase digestion (Fig. 3, above, left 
and Table 1). The number of stromal vascular frac-
tion cells in lipoconcentrate (1.045 ± 0.071 × 106 
cells/g) was significantly higher than in nanofat 
(0.642 ± 0.036 × 106 cells/g; p < 0.01) and native 
fat (0.698 ± 0.065 × 106 cells/g; p < 0.05). The oily 
fraction of lipoconcentrate was markedly larger 
than the oily fraction in general. In both oily frac-
tions, the stromal vascular fraction cell number 
fell below the detection limit.
Adipose-Derived Stem Cell Count
Adipose-derived stem cells were defined as 
CD31− (endothelial marker), CD34+ (stem cell 
marker), CD45− (hematopoietic marker) cells 
(Fig. 3, above, right).12 Lipoconcentrate showed a 
significantly higher adipose-derived stem cell con-
centration (0.229 ± 0.021 × 106 cells/g) compared 
with any other fraction (p < 0.01 or p < 0.001) 
(Table 1) and more than two-fold more adipose-
derived stem cells compared with native fat (0.054 
± 0.008 × 106 cells/g). The oily fractions both 
showed no or small numbers of adipose-derived 
stem cells.
Endothelial Progenitor Cell Count
A similar trend was seen for CD31+, CD34+, 
CD45− endothelial progenitor cells (Fig. 3, below). 
Lipoconcentrate showed by far the highest endo-
thelial progenitor cell concentrations (Table 2). A 
significant difference was found between lipocon-
centrate (0.389 ± 0.089 × 105 cells/g) and native 
fat (0.096 ± 0.027 × 105 cells/g; p < 0.01), 1× cen-
trifuged native fat (0.145 ± 0.045 × 105 cells/g; p < 
0.05), and 2× centrifuged native fat (0.171 ± 0.058 
× 105 cells/g; p < 0.05). Both oily fractions showed 
very few endothelial progenitor cells.
Relative Expression of CD73, CD90, and CD105 
on Adipose-Derived Stem Cells and Endothelial 
Progenitor Cells
Next, the relative expression of the mesen-
chymal markers CD73, CD90, and CD105 on 
the adipose-derived stem cells was measured 
(Fig. 4, left).13 However, no significant differ-
ences were seen in the relative ratios of CD73+, 
CD90+, CD105+, and CD73+/CD90+/CD105+ 
adipose-derived stem cells. We refrained from 
characterizing CD73, CD90, and CD105 on 
adipose-derived stem cells of the oily fractions 
as the number of cells was too small (data not 
shown).
Table 1. Significant Differences in Adipose-Derived Stem Cell Content 
 
1× Centrifuged 
Native Fat
2× Centrifuged 
Native Fat Nanofat
1× Centrifuged 
Nanofat Lipoconcentrate
Oily  
Fraction
Oily Fraction 
of Nanogel
Native fat NS NS NS NS *** NS NS
1× centrifuged native fat  NS NS NS *** * NS
2× centrifuged native fat   NS NS *** ** *
Nanofat    NS *** ** *
1× centrifuged nanofat     ** *** ***
Lipoconcentrate      *** ***
Oily fraction       NS
NS, not significant.
*p < 0.05.
**p < 0.01.
***p < 0.001. 
Table 2. Significant Differences in Endothelial Progenitor Cell Content 
 
1× Centrifuged 
Native Fat
2× Centrifuged 
Native Fat Nanofat
1× Centrifuged 
Nanofat Lipoconcentrate
Oily  
Fraction
Oily Fraction 
of Nanogel
Native fat NS NS NS NS ** NS NS
1× centrifuged native fat  NS NS NS * * *
2× centrifuged native fat   NS NS * * *
Nanofat    NS NS ** **
1× centrifuged nanofat     NS *** ***
Lipoconcentrate      *** ***
Oily fraction       NS
NS, not significant.
*p < 0.05.
**p < 0.01.
***p < 0.001. 
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Fig. 4. CD73, CD90, and CD105 expression on adipose-derived stem 
cells (ASCs) and endothelial progenitor cells (EPCs). Relative expression
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Relative CD73, CD90, and CD105 expression 
on endothelial progenitor cells showed no sig-
nificant differences among the fractions (Fig. 4, 
right). We again refrained from characterizing 
CD73, CD90, and CD105 on endothelial progeni-
tor cells of the oily fractions, as their number was 
too low (data not shown).
DISCUSSION
In the present study, we propose a modifica-
tion of Tonnard et al.’s original nanofat grafting 
protocol by double centrifugation eliciting an 
even more liquid lipoaspirate called lipoconcen-
trate. Some authors regard centrifugation to be 
a superfluous method and rather advocate more 
conservative processing techniques such as decan-
tation, washing, or even immediate reinjection 
without any processing method applied at all.14 In 
our view, centrifugation has its raison d’être, as it 
is a safe, simple, and effective measure to separate 
the lipoaspirate from fractions with few progenitor 
cells and soluble factors.2,15 Although we showed 
earlier that the watery layer of lipoaspirates after 
centrifugation contained significantly lower levels 
of growth factors compared with purified fat,2 in 
the current study, we also found significantly lower 
levels of soluble factors and progenitor cells in the 
oily fractions. In other words, from the perspec-
tive of regenerative potential, we do not see any 
rationale to keep the watery or the oily fraction, as 
they occupy unnecessary volume devoid of regen-
erative cells and soluble factors. Also, superfluous 
oil may be a reason for volume loss of the fat graft 
and oil cysts.16
We have found increasing numbers of stromal 
vascular fraction cells, adipose-derived stem cells, 
and endothelial progenitor cells per gram of tis-
sue with each centrifugation step in the native and 
the emulsified fractions. The lipoconcentrate had 
by far the highest adipose-derived stem cell and 
endothelial progenitor cell counts. We assume two 
reasons for this observation. First, the elimination 
of oily and watery layers by centrifugation leads 
to a relative increase in cells per gram of starting 
material. The particularly voluminous oily layer 
after the second centrifugation step of the emul-
sified fat could explain the remarkable increase 
of cells per gram of tissue between 1× centri-
fuged nanofat and lipoconcentrate. Mashiko et al. 
observed that emulsification of lipoaspirates led to 
damage of adipocytes and an increase of adipose-
derived stem cells and endothelial cells compared 
with centrifuged and squeezed lipoaspirates.17 
They also found few adipose-derived stem cells in 
the residual fluid after filtration of emulsified fat, 
which is in line with our observations. The second 
explanation is a potential phenotypic change of 
stromal vascular fraction cell fractions by mechan-
ical forces as demonstrated by Banyard et al., 
who found altered marker expression by nanofat 
processing.18 The fact that lipoconcentrate shows 
higher progenitor cell counts than 1× centrifuged 
nanofat and 1× and 2× centrifuged native fat indi-
cates that only a combination of emulsification 
and two centrifugation steps—which is the key of 
our technique—results in the significant increase 
in adipose-derived stem cell and endothelial pro-
genitor cell enrichment found in lipoconcentrate.
We chose two separate centrifugation steps for 
the preparation of lipoconcentrate for the follow-
ing reasons: the first centrifugation step immedi-
ately after harvest clears the fat graft of potentially 
harmful other fractions, including the tumescent 
solution, and allows emulsification of the relevant 
adipose tissue fraction. The second centrifugation 
step then eliminates the remnants of the lysed 
cells. A longer first centrifugation period may 
not address the second issue and vice versa. We 
did refrain from increasing centrifugation force, 
as the settings proposed by Coleman are most 
widely used, and several studies suggest 1200 g as 
appropriate, with higher forces potentially being 
harmful.6,7
Progenitor cell enrichment generally is pos-
sible by either mechanical or enzymatic methods. 
Enzymatic methods rely on enzymatic digestion of 
the collagen in the extracellular matrix amended 
by centrifugation, filtering, and washing.19 There 
is little contention that enzymatic methods yield 
higher progenitor cell numbers. At the same 
time, however, it entails regulatory issues and 
risk of contamination and, above all, requires a 
fully equipped laboratory facility. To bypass the 
aforementioned issues, semiautomated and fully 
automated systems were developed.20,21 Major 
drawback to the commercially available systems 
are their high acquisition and maintenance costs, 
inconsistent cellular yield and—depending on the 
device—long preparation time.19 Tonnard et al.’s 
original nanofat-graft technique, Mashiko et al.’s 
technique of nanofat preparation of centrifuged 
fat, and now our lipoconcentrate preparation 
Fig. 4. (Continued). of the mesenchymal markers CD73, CD90, 
and CD105 on (left) adipose-derived stem cells (CD31−, CD34+, 
CD45−) and (right) endothelial progenitor cells (CD31+, CD34+, 
CD45−) on the cell surface was measured by flow cytometry. All 
data are presented as means ± SEM. No statistical differences 
between fractions were observed.
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protocol therefore represent attractive alterna-
tives, as they only require a centrifuge, standard 
syringes, and a female-to-female Luer-Lok con-
nector. Moreover, our protocol can be performed 
in less than 10 minutes in the operating room.
There also is an ongoing debate on the most 
efficient fat graft processing technique, including 
washing, gravity separation, filtration, and centrif-
ugation. Although the literature is not conclusive, 
centrifugation as part of Sydney Coleman’s estab-
lished protocol is widely used, and its efficacy is 
supported by several experimental studies.9 Clini-
cal studies have also shown increased longevity 
and better aesthetic outcome of centrifuged fat 
compared with noncentrifuged fat10 and no nod-
ule formulation of centrifuged fat compared with 
filtered fat.11 At the same time, aesthetic results of 
centrifuged fat appear to be comparable to those 
of costly automated fat graft processing devices.12 
The true value of lipoconcentrate compared with 
commercially available systems, enzymatic diges-
tion, and other processing techniques, however, is 
subject to future research.
We characterized adipose-derived stem cells 
and endothelial progenitor cells by their surface 
CD34 expression. Besides CD34, adipose-derived 
stem cells and endothelial progenitor cells also 
express other central stem cell markers, of which 
CD73, CD90, and CD105 were selected as mini-
mum criteria for multipotent mesenchymal stem 
cells by the International Society for Cellular 
Therapy13 and are frequently used to characterize 
cells of the stromal vascular fraction.12,22 However, 
our results indicate that processing techniques 
such as centrifugation and emulsification gener-
ally did not have any influence on CD73, CD90, 
and CD105 expression of endothelial progenitor 
cells and adipose-derived stem cells.
Fat grafts contain and secrete copious amounts 
of soluble factors that orchestrate tissue homeo-
stasis.23 We have chosen a panel of four growth 
factors and the enzyme MMP-9, as their regenera-
tive effect is well documented in the literature. In 
fact, several in vivo studies have shown improved 
fat graft retention and vascularization by supple-
mentation of bFGF,24 IGF-1,25 PDGF,26 and VEGF.27 
MMP-9 is a well-studied enzyme for extracellular 
matrix degradation and is involved in adipose tis-
sue differentiation and wound remodeling.28,29 
In an earlier publication, we have shown that the 
content of growth factors is significantly lower in 
the watery phase compared with the purified fat.2 
Lipoconcentrate contained substantial concen-
trations of the aforementioned soluble factors. 
Nonetheless, no statistical difference between 
lipoconcentrate and the other fat tissue–con-
taining fractions was present, suggesting that the 
regenerative property of lipoconcentrate may pri-
marily originate from progenitor cells.
From a clinical point of view, the lipoconcen-
trate may be particularly useful for the treatment 
of areas where a regenerative effect of fat graft by 
means of adipose-derived stem cells and endothe-
lial progenitor cells is desired more than a volume 
expansion. Indications include the rejuvenation 
of the perioral or buccal area or the treatment of 
scars, where progenitor cells contribute to restora-
tion of the epidermis and dermis1,2 and improve 
scar appearance.3 The lipoconcentrate also may 
be useful for the treatment of chronic wounds 
with malperfusion. In these wounds, limited vas-
cularization prevents voluminous fat grafts from 
promptly receiving blood supply from the sur-
rounding tissue and thus results in fat necrosis.4 In 
this context, transplanted endothelial progenitor 
cells in particular may assist in neovascularization.5
CONCLUSIONS
In the present work, we introduce a new 
method of fat graft processing that includes cen-
trifugation of the harvested fat followed by emulsi-
fication and a second centrifugation step resulting 
in a graft termed lipoconcentrate. The lipoconcen-
trate contains significantly higher levels of adipose-
derived stem cells and endothelial progenitor cells 
but unaltered soluble factor levels compared with 
other fractions. We assume that emulsification leads 
to a disruption of adipocytes that are eliminated by 
centrifugation, ultimately concentrating progeni-
tor cells per gram of tissue. Lipoconcentrates may 
be particularly useful for applications where the tis-
sue regeneration is desired more than a volumetric 
effect. Our work is primarily of a descriptive nature, 
and translation of our experiments in animal stud-
ies is necessary to draw a conclusion on the clinical 
relevance of our results.
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